Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $6.
Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $6.